[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE411211B - Forfarande for framstellning av 3-halogencefalosporiner - Google Patents

Forfarande for framstellning av 3-halogencefalosporiner

Info

Publication number
SE411211B
SE411211B SE7402414A SE7402414A SE411211B SE 411211 B SE411211 B SE 411211B SE 7402414 A SE7402414 A SE 7402414A SE 7402414 A SE7402414 A SE 7402414A SE 411211 B SE411211 B SE 411211B
Authority
SE
Sweden
Prior art keywords
phalosporins
halogence
procedure
preparation
halogence phalosporins
Prior art date
Application number
SE7402414A
Other languages
English (en)
Inventor
R R Chauvette
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE411211B publication Critical patent/SE411211B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7402414A 1973-02-23 1974-02-22 Forfarande for framstellning av 3-halogencefalosporiner SE411211B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33541473A 1973-02-23 1973-02-23

Publications (1)

Publication Number Publication Date
SE411211B true SE411211B (sv) 1979-12-10

Family

ID=23311677

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7402414A SE411211B (sv) 1973-02-23 1974-02-22 Forfarande for framstellning av 3-halogencefalosporiner

Country Status (34)

Country Link
JP (4) JPS612677B2 (sv)
AR (3) AR208068A1 (sv)
AT (1) AT333952B (sv)
BE (1) BE811494A (sv)
BG (1) BG22404A3 (sv)
BR (1) BR7401385D0 (sv)
CA (1) CA1032532A (sv)
CH (1) CH594686A5 (sv)
CS (1) CS189625B2 (sv)
CY (1) CY1042A (sv)
DD (1) DD110277A5 (sv)
DE (1) DE2408686C2 (sv)
ES (1) ES423532A1 (sv)
FI (1) FI63240C (sv)
FR (1) FR2218878B1 (sv)
GB (1) GB1458293A (sv)
GT (1) GT197432132A (sv)
HK (1) HK19980A (sv)
HU (1) HU167749B (sv)
IE (1) IE38916B1 (sv)
IL (1) IL44263A (sv)
KE (1) KE3026A (sv)
MW (1) MW574A1 (sv)
MY (1) MY8100023A (sv)
NL (1) NL181010C (sv)
NO (2) NO148376C (sv)
OA (1) OA04688A (sv)
PH (1) PH14014A (sv)
PL (1) PL88714B1 (sv)
RO (1) RO64595A (sv)
SE (1) SE411211B (sv)
YU (2) YU36971B (sv)
ZA (1) ZA741190B (sv)
ZM (1) ZM3674A1 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
CH622802A5 (sv) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
JPS62112053U (sv) * 1985-12-27 1987-07-16
JPH0676861B2 (ja) * 1988-05-24 1994-09-28 リンナイ株式会社 温風暖房機の制御装置
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2265798C2 (de) * 1971-06-24 1985-09-26 Fujisawa Pharmaceutical Co., Ltd., Osaka Verfahren zur Herstellung von Oxoazetidin-Derivaten

Also Published As

Publication number Publication date
AU6591574A (en) 1975-08-28
NL7402486A (sv) 1974-08-27
FR2218878B1 (sv) 1977-03-11
YU46374A (en) 1982-06-18
ZM3674A1 (en) 1975-11-21
CS189625B2 (en) 1979-04-30
PL88714B1 (en) 1976-09-30
GB1458293A (en) 1976-12-15
JPS613358B2 (sv) 1986-01-31
JPS613357B2 (sv) 1986-01-31
KE3026A (en) 1980-03-14
YU37347B (en) 1984-08-31
FI63240B (fi) 1983-01-31
GT197432132A (es) 1975-08-16
DE2408686C2 (de) 1986-08-28
PH14014A (en) 1980-12-08
JPS613356B2 (sv) 1986-01-31
NO148376C (no) 1983-09-28
CH594686A5 (sv) 1978-01-31
BG22404A3 (bg) 1977-02-20
HK19980A (en) 1980-04-25
BR7401385D0 (pt) 1974-11-05
DD110277A5 (sv) 1974-12-12
DE2408686A1 (de) 1974-09-05
ZA741190B (en) 1975-09-24
JPS56138193A (en) 1981-10-28
IE38916L (en) 1974-08-23
CA1032532A (en) 1978-06-06
OA04688A (fr) 1980-07-31
AT333952B (de) 1976-12-27
NL181010B (nl) 1987-01-02
ES423532A1 (es) 1976-06-01
NO792609L (no) 1974-08-26
MW574A1 (en) 1975-05-13
FR2218878A1 (sv) 1974-09-20
JPS612677B2 (sv) 1986-01-27
MY8100023A (en) 1981-12-31
HU167749B (sv) 1975-12-25
NO740607L (no) 1974-08-26
NO148376B (no) 1983-06-20
YU99880A (en) 1983-04-27
AR201709A1 (es) 1975-04-08
RO64595A (ro) 1981-01-30
IE38916B1 (en) 1978-06-21
BE811494A (fr) 1974-08-22
IL44263A0 (en) 1974-05-16
JPS49116095A (sv) 1974-11-06
ATA142474A (de) 1976-04-15
JPS56138194A (en) 1981-10-28
IL44263A (en) 1977-10-31
AR200908A1 (es) 1974-12-27
CY1042A (en) 1980-08-01
NL181010C (nl) 1987-06-01
YU36971B (en) 1984-08-31
FI63240C (fi) 1983-05-10
AR208068A1 (es) 1976-11-30
JPS56138195A (en) 1981-10-28

Similar Documents

Publication Publication Date Title
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
NO145273C (no) N-formyl-alfa-l-aspartyl-l-fenylalanin for anvendelse til fremstilling av alfa-l-aspartyl-l-fenylalaninalkylestere
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE420604B (sv) Forfarande for framstellning av oxazolderivat
NO142628C (no) Fremgangsmaate for fremstilling av polylaktoner
RO70474A (ro) PROCEDEU PENTRU PREPARAREA PARAXILENULёI
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
SE417721B (sv) Forfarande for framstellning av fenol-aldehydskumplast
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
NO140928C (no) Fremgangsmaate for fremstilling av xylitol
TR17584A (tr) Herbisid triazinlerinin hazirlanmasina mahsus usul
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
AR206610A1 (es) Procedimiento de preparacion de 2-metoxi-5-sulfonil(sustituidos)-benzamidas-(-sustituidas
SE409716B (sv) Analogiforfarande for framstellning av 11beta-alkyl-deltaŸ4-estrener
SE7608956L (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
NO143746C (no) Fremgangsmaate for fremstilling av poly-n-isopropyl-iminoalaner
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7402414-2

Effective date: 19940310

Format of ref document f/p: F